EFTUD2 is a peptide modeled on a spliceosomal GTP-binding protein, reflecting regions vital for partner recognition. The sequence enables exploration of folding, charge distribution, and local interaction motifs. Researchers use it to map contacts important for splicing-factor assembly. Its structure supports biochemical and conformational studies.
CAT No: ta-200
EFTUD2, also known as Elongation Factor Tu GTP Binding Domain Containing 2, is a highly conserved protein that plays a critical role in the spliceosomal machinery of eukaryotic cells. As a core component of the U5 small nuclear ribonucleoprotein (snRNP) complex, EFTUD2 is fundamentally involved in the catalysis of pre-mRNA splicing, a process essential for the generation of mature messenger RNA transcripts. Its GTPase activity and participation in dynamic conformational changes within the spliceosome underscore its importance in regulating gene expression at the post-transcriptional level. The protein's functional significance is highlighted by its evolutionary conservation and its association with key regulatory events in RNA processing pathways, making it a valuable focus for researchers investigating the molecular mechanisms of splicing and related genetic processes.
Spliceosome research: EFTUD2 is widely utilized in studies aimed at elucidating the structure and function of the spliceosome, particularly the U5 snRNP complex. Researchers employ recombinant forms, antibodies, or expression constructs of this protein to dissect its mechanistic contributions to the assembly and catalytic activity of the spliceosome. By enabling detailed investigations into the molecular interactions and conformational transitions that govern pre-mRNA splicing, EFTUD2 serves as a pivotal tool in advancing our understanding of eukaryotic gene regulation and the fidelity of mRNA maturation.
RNA-protein interaction studies: The protein's involvement in dynamic RNA-protein complexes makes it an ideal candidate for studies focused on mapping the interactome of spliceosomal components. Techniques such as co-immunoprecipitation, crosslinking, and mass spectrometry often leverage EFTUD2 to identify and characterize its binding partners. These applications provide critical insights into the modular architecture of the spliceosome and facilitate the discovery of novel regulatory factors that modulate mRNA splicing efficiency and specificity.
Genetic and functional genomics research: Functional genomics approaches frequently target EFTUD2 to assess its role in cellular physiology and gene expression networks. RNA interference, CRISPR-based gene editing, and overexpression systems are employed to modulate its expression in cell lines or model organisms, enabling researchers to analyze the downstream effects on transcriptome diversity, alternative splicing patterns, and cellular phenotype. These studies are instrumental in identifying genetic dependencies and vulnerabilities associated with RNA processing pathways.
Disease mechanism exploration: Dysregulation or mutation of the gene encoding EFTUD2 has been implicated in various developmental and cellular disorders. As such, it is a key focus in research investigating the molecular basis of spliceosomopathies and other RNA-processing-related diseases. Using patient-derived samples, engineered cell models, or biochemical assays involving this protein, scientists can delineate the causative links between spliceosomal dysfunction and disease phenotypes, thus contributing to the broader understanding of RNA biology in health and disease.
Biochemical assay development: The unique enzymatic and structural properties of EFTUD2 make it a valuable target for the development of in vitro assays designed to monitor spliceosome assembly, GTPase activity, and protein-protein interactions. These assays are essential for high-throughput screening of modulators, mechanistic studies of splicing regulation, and the validation of novel molecular tools. By enabling precise quantification and manipulation of spliceosomal dynamics, EFTUD2-based assays support a wide range of experimental and analytical applications in molecular biology and biochemistry.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More